Geriatric Care for Breast Cancer Survivors
Trial Summary
Do I need to stop my current medications for this trial?
The trial does not specify if you need to stop taking your current medications. It seems you can continue with certain treatments like radiation, HER-2 targeted agents, and endocrine therapy.
What data supports the effectiveness of the treatment Comprehensive Geriatric Assessment for breast cancer survivors?
Research shows that Comprehensive Geriatric Assessment (CGA) helps identify health issues in older breast cancer survivors, allowing for tailored care plans that maintain their functional status and improve quality of life. In a study, CGA improved patients' quality of life scores and maintained their independence, highlighting its effectiveness in addressing multiple health problems.12345
Is the Comprehensive Geriatric Assessment safe for older adults, including breast cancer survivors?
How is the treatment Comprehensive Geriatric Assessment different from other treatments for breast cancer survivors?
Comprehensive Geriatric Assessment is unique because it systematically evaluates older breast cancer survivors to identify risks of functional decline, allowing for personalized care plans to maintain their independence and quality of life. Unlike standard cancer treatments, it involves a multidisciplinary team approach, including assessments by various specialists like physical therapists and nutritionists, to address the broader health needs of older patients.137910
What is the purpose of this trial?
This trial studies the effect of a geriatric care survivorship intervention in improving the overall health of older adults who have completed curative treatment for stage I-III breast cancer. Geriatric assessment is the complete examination of an elderly individual, which includes a full valuation of the physical and mental conditions, as well as a check of emotional state. Geriatric assessment and survivorship visits after treatment may reduce health burdens and improve the well-being and quality of life of elderly patients with breast cancer. Researchers hope to improve the overall health of older adults who have undergone curative treatment for stage I-III breast cancer.
Research Team
Meghan Karuturi, MD
Principal Investigator
M.D. Anderson Cancer Center
Eligibility Criteria
This trial is for older adults who are at least 65 years old and have recently completed treatment for early-stage breast cancer (Stage I-III). They must be able to consent, speak English or Spanish, and meet all study requirements. Caregivers can also participate if they're over 18. People with significant medical conditions that prevent exercise participation cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete a geriatric assessment to evaluate physical, mental, and emotional conditions
Intervention
Participants receive a GA-guided intervention, survivorship care educational materials, and a wearable activity tracking device
Follow-up
Participants are monitored for safety and effectiveness after intervention, including assessments at 6 and 12 months
Treatment Details
Interventions
- Comprehensive Geriatric Assessment
- Health Education
- Supportive Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator